BlueWillow Biologics, Inc.

BlueWillow is a clinical-stage biotech company focused on developing intranasal allergy & infectious disease vaccines using its patented NanoVax® platform

  • Stage Product In Development
  • Industry Biotechnology
  • Location Ann Arbor, MI, USA
  • Currency USD
  • Founded January 2017
  • Employees 14
  • Incorporation Type C-corp
  • Website bluewillow.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free